NCT01192425View on ClinicalTrials.gov

Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes

CompletedOBSERVATIONAL

Enrollment

5,580

Participants

Timeline

Start Date

Not specified

Conditions

Hemoglobinuria

Sponsors

Lead Sponsor

Alexion Pharmaceuticals, Inc.

All Listed Sponsors

lead

Alexion Pharmaceuticals, Inc.

INDUSTRY

NCT01192425 - Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes | Biotech Hunter | Biotech Hunter